Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (311-320 of 560) with videos related to

Pageof 56
Sort By:
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2014
A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-careBasil H Shadfan, Archana R Simmons, Glennon W Simmons, et al.
Oncogene|May 29, 2003
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancersRobert Z Luo, Xianjun Fang, Rebecca Marquez, et al.
Cancer|June 25, 1992
Detection of a novel marker in the bronchial secretions of patients with non-small cell lung cancer using the 4B5 monoclonal antibodyM A Deutsch, J C Pence, B J Kerns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
BMC Cancer|January 20, 2011
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxelChun-Fang Zou, Luoqi Jia, Hongyan Jin, et al.
Cancer Research|March 3, 2006
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancerZendra Lee, Ramona F Swaby, Yuewei Liang, et al.
Journal of Hematotherapy|February 1, 1996
A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrowJ J Vredenburgh, O Silva, C Tyer, et al.
Methods in Enzymology|June 8, 2006
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancersYinhua Yu, Robert Luo, Zhen Lu, et al.
Pageof 56

Showing results (311-320 of 560) with videos related to

Sort By:
Pageof 56
American Journal of Obstetrics and Gynecology|July 1, 1984
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenR C Bast, T L Klug, E Schaetzl, et al.
Gynecologic Oncology|May 1, 1988
An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaV R Zurawski, R C Knapp, N Einhorn, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 13, 2014
A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-careBasil H Shadfan, Archana R Simmons, Glennon W Simmons, et al.
Oncogene|May 29, 2003
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancersRobert Z Luo, Xianjun Fang, Rebecca Marquez, et al.
Cancer|June 25, 1992
Detection of a novel marker in the bronchial secretions of patients with non-small cell lung cancer using the 4B5 monoclonal antibodyM A Deutsch, J C Pence, B J Kerns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumorsD M Gershenson, M Deavers, S Diaz, et al.
BMC Cancer|January 20, 2011
Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxelChun-Fang Zou, Luoqi Jia, Hongyan Jin, et al.
Cancer Research|March 3, 2006
Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancerZendra Lee, Ramona F Swaby, Yuewei Liang, et al.
Journal of Hematotherapy|February 1, 1996
A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrowJ J Vredenburgh, O Silva, C Tyer, et al.
Methods in Enzymology|June 8, 2006
Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancersYinhua Yu, Robert Luo, Zhen Lu, et al.
Pageof 56